Neuroactive chondroitin sulfate glycomimetics by Rawat, Manish et al.
 S1 
-Supporting Information- 
 
Neuroactive Chondroitin Sulfate Glycomimetics 
Manish Rawat, Cristal I. Gama, John B. Matson, and Linda C. Hsieh-Wilson* 
Division of Chemistry and Chemical Engineering and Howard Hughes Medical Institute, California 
Institute of Technology, Pasadena, California 91125 
 
 
  
General Methods 
Unless otherwise stated, reactions were performed in flame-dried glassware under an argon 
atmosphere, using dry solvents. Solvents were dried by passage through an activated alumina column 
under argon. All other commercially obtained reagents were used as received unless otherwise noted. Thin 
layer chromatography (TLC) was performed using E. Merck silica gel 60 F254 precoated plates (0.25 mm). 
Visualization of the developed chromatogram was performed by UV, cerium ammonium molybdate and 
ninhydrin stain as necessary. ICN silica gel (particle size 0.032 - 0.063 mm) was used for flash 
chromatography. Gel filtration chromatography (Sephadex G-10 and G-25 ultrafine) was used in order to 
achieve purification of the final products. 
1H NMR and proton decoupling experiments were recorded on Varian Mercury 300 (300 MHz) 
and Varian Mercury 600 (600 MHz) spectrometers and are reported in parts per million (δ) relative to 
CDCl3 (7.26 ppm), CD3OD (4.87 ppm) and D2O (4.80 ppm).  Data for 1H are reported as follows: chemical 
shift (δ ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), coupling 
constant in Hz, and integration. 13C NMR spectra were obtained on a Varian Mercury 300 (75 MHz) 
spectrometer and are reported in terms of chemical shift. Mass spectra were obtained from the 
Protein/Peptide MicroAnalytical Laboratory and the Mass Spectrometry Facility at the California Institute 
of Technology. 
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2-(2-(Cyclooct-4-enyloxy)ethoxy)ethyl (methyl 2,3-di-O-benzoyl-4-O-
tert-butyldimethylsilyl-β-D-glucopyranosyluronate)-(1 → 3)-4,6-O-p-
methoxybenzylidene-2-deoxy-2-trichloroacetamido-D-galactopyranoside (3):  A mixture of donor 1 
(0.750 g, 0.680 mmol) and acceptor 2 (0.300 g, 2.02 mmol) was co-evaporated with toluene (3 x 3 mL) 
and dried under vacuum overnight. The mixture was dissolved in CH2Cl2 (9.0 mL), and activated 4Å 
powdered molecular sieves were added. After stirring at rt for 30 min, the reaction was cooled to -75 °C and 
stirred for an additional 30 min. Trimethylsilyl trifluoromethanesulfonate (1 M in CH2Cl2, 125 µL, 0.123 
mmol) at -75 °C was added to the reaction dropwise. The reaction mixture was warmed to -20 °C, stirred 
for 30 min, quenched with triethylamine, filtered through Celite® and concentrated to afford a yellow syrup. 
Purification by flash chromatography (30% EtOAc:toluene) afforded 3 (0.460 g, 69%) as a white solid. Rf 
0.40 (30% EtOAc:toluene). 1H NMR (500 MHz, CDCl3): δ 7.92 – 7.84 (m, 4 H, ArH), 7.54 – 7.46 (m, 2 H, 
ArH), 7.42 (d, J = 8.5 Hz, 2 H, C6H4OMe), 7.31 (dd, J = 7.5, 7.5 Hz, 2 H, ArH), 7.28 (dd, J = 7.5, 7.5 Hz, 2 
H, ArH), 6.85 (d, J = 9.0 Hz, 2 H, C6H4OMe), 6.81 (d, J = 7.0 Hz, 1 H, NH), 5.68 – 5.51 (m, 2 H, 
CH=CH), 5.46 (dd, J = 8.5, 8.5 Hz, 1 H, H-3'), 5.43 (s, 1 H, MeOPhCH), 5.39 (dd, J = 7.0, 7.0 Hz, 1 H, H-
2'), 5.06 (d, J = 7.5 Hz, 1 H, H-1'), 5.04 (d, J = 8.0 Hz, 1 H, H-1), 4.63 (dd, J = 3.5, 11.0 Hz, 1 H, H-3), 
4.34 (d, J = 4.5 Hz, 1 H, H-4), 4.32 (dd, J = 8.5, 9.5 Hz, 1 H, H-4'), 4.26 (d, J = 12.0 Hz, 1 H, H-6), 4.09 (d, 
J = 9.5 Hz, 1 H, H-5'), 4.03 (d, J = 11.5 Hz, 1 H, H-7), 3.97 – 3.90 (m, 1 H, OCH2CH2O), 3.78 (s, 3 H, 
CO2CH3), 3.77 (s, 3 H, PhOCH3), 3.76 – 3.62 (m, 2 H, H-2, OCH2CH2O), 3.60 – 3.54 (m, 2 H, 
OCH2CH2O), 3.53 – 3.39 (m, 5 H, H-5, OCH2CH2O), 3.32 – 3.26 (m, 1 H, OCH of COE), 2.36 – 2.22 (m, 1 
H, CH2 of COE), 2.18 – 1.84 (m, 3 H, CH2 of COE), 1.93 – 1.82 (m, 1 H, CH2 of COE), 1.80 – 1.58 (m, 3 
H, CH2 of COE), 1.48 – 1.28 (m, 2 H, CH2 of COE), 0.70 (s, 9 H, SiC(CH3)3), -0.09 (s, 3 H, SiCH3), -0.25 
(s, 3 H, SiCH3); 13C NMR (75 MHz, CDCl3): δ 168.6, 165.5, 165.1, 162.1, 159.8, 133.2, 131.1, 130.3, 
130.0,  129.8, 129.7, 129.4, 129.4, 129.0, 128.3, 128.3, 127.5, 113.4, 100.5, 100.2, 98.7, 81.0, 76.1, 75.4, 
75.4, 73.4, 71.7, 70.8, 70.6, 70.4, 68.9, 68.4, 67.6, 67.6, 66.5, 55.3, 54.9, 52.5, 34.1, 34.1, 33.4, 33.4, 25.8, 
25.6, 25.6, 25.4, 22.6, 17.7, -4.5, -5.2; ESI MS: m/z calcd for [C55H70Cl3NO17Si + H]+: 1150.3, obsd 1150.6. 
 
O
O
BzO
BzO
TBSO O
O
O
2
O
O
pMP
MeO2C
TCAHN
3
 S3 
 
2-(2-(Cyclooct-4-enyloxy)ethoxy)ethyl (methyl 2,3-di-O-benzoyl-β-D- 
glucopyranosyluronate)-(1 → 3)-4,6-O-p-methoxybenzylidene-2-deoxy-2-
trichloroacetamido-D-galactopyranoside (4):  A solution of 3 (0.410 g, 0.356 mmol) in dry THF (5.5 
mL) and pyridine (5.5 mL) was cooled to 0 °C. HF•pyridine (1.30 mL, 70% HF in pyridine) was added, 
and the reaction mixture was warmed to rt and stirred for 12 h. The mixture was then diluted with EtOAc 
and washed with 10% aqueous CuSO4. The aqueous phase was extracted with EtOAc (3x), and the 
combined organics were washed with saturated aqueous NaHCO3 and dried over MgSO4. The solvent was 
removed in vacuo to afford a yellow oil, which was purified by flash chromatography (50 → 90% 
EtOAc:hexanes) to afford 4 (0.358 g, 95%) as a white solid. Rf 0.40 (80% EtOAc:hexanes). 1H NMR (500 
MHz, CDCl3): δ 7.93 (dd, J = 1.0, 8.5 Hz, 2 H, ArH), 7.89 (dd, J = 1.5, 8.0 Hz, 2 H, ArH), 7.52 – 7.46 (m, 
2 H, ArH), 7.42 (d, J = 11.5 Hz, 2 H, C6H4OMe), 7.39 – 7.30 (m, 4 H, ArH), 7.06 (d, J = 6.5 Hz, 1 H, NH), 
6.87 (d, J = 11.5 Hz, 2 H, C6H4OMe), 5.68 – 5.54 (m, 2 H, CH=CH of COE), 5.48 (s, 1 H, MeOPhCH), 
5.47 (dd, J = 8.0, 8.0 Hz, 1 H, H-2), 5.44 (dd, J = 8.0, 8.0 Hz, 1 H, H-3), 5.19 (d, J = 7.0 Hz, 1 H, H-1), 
5.13 (d, J = 8.0 Hz, 1 H, H-1), 4.57 (ddd, J = 1.0, 3.5, 11.0 Hz, 1 H, H-3), 4.41 (d, J = 3.5 Hz, 1 H, H-4), 
4.29 (dd, J = 1.5, 12.5 Hz, 1 H, H-6), 4.21 (dd, J = 9.0, 9.0 Hz, 1 H, H-4'), 4.10 (d, J = 10.0 Hz, 1 H, H-5'), 
4.04 (dd, J = 1.5, 13.5 Hz, 1 H, H-7'), 3.97 (td, J = 5.0, 11.5 Hz, 1 H, OCH2CH2O ), 3.85 (s, 3 H, CO2CH3), 
3.81 (s, 3 H, PhOCH3), 3.78 – 3.65 (m, 2 H, H-2, OCH2CH2O), 3.60 (t, J = 4.5 Hz, 2 H, OCH2CH2O), 3.55 
– 3.42 (m, 6 H, H-5, OCH2CH2O, OH), 3.35 – 3.25 (m, 1 H, OCH of COE), 2.36 – 2.26 (m, 1 H, CH2 of 
COE), 2.16 – 1.98 (m, 3 H, CH2 of COE), 1.96 – 1.86 (m, 1 H, CH2 of COE), 1.74 – 1.60 (m, 3 H, CH2 of 
COE), 1.52 – 1.30 (m, 2 H, CH2 of COE); 13C NMR (75 MHz, CDCl3): δ 169.2, 166.5, 165.0, 162.1, 159.9, 
133.4, 133.3, 130.2, 130.0, 129.9, 129.8, 129.4, 129.0, 128.8, 128.4, 128.4, 127.3, 113.4, 100.4, 100.3, 
98.6, 92.2, 81.0, 77.2, 75.2, 74.0, 73.9, 71.1, 70.7, 70.4, 69.0, 68.5, 67.6, 66.5, 55.3, 55.0, 53.0, 34.1, 33.4, 
25.7, 25.6, 22.6; ESI MS: m/z calcd for [C49H56NO17Si + Na]+: 1058.2, obsd 1058.5. 
 
2-(2-(Cyclooct-4-enyloxy)ethoxy)ethyl (methyl 2,3-di-O-benzoyl-4-O- 
tert-butyldimethylsilyl-β-D-glucopyranosyluronate)-(1 → 3)-4,6-O-p-
methoxybenzylidene-2-deoxy-2-acetamido-β-D-galactopyranoside (3a):  Reduction of the N-
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trichloroacetyl group was performed using a procedure modified from Bélot et. al.1 To a solution of 
disaccharide 3 (0.250 g, 0.217 mmol) in benzene (7.8 mL) were added tributylstannane (305 µL, 1.51 
mmol) and 2,2’- azobisisobutyronitrile (0.080 g). After stirring at rt for 45 min, the reaction mixture was 
heated to 80 °C and stirred for an additional 1.5 h. The reaction was then cooled to rt and concentrated to 
afford a white solid. Purification by flash chromatography (50 → 90% EtOAc:hexanes) afforded acetamide 
3a (0.209 g, 92%) as a white solid. Rf 0.30 (EtOAc). 1H NMR (500 MHz, CDCl3): δ 7.91 (d, J = 8.5 Hz, 2 
H, ArH), 7.90 (d, J = 8.5 Hz, 2 H, ArH), 7.50 (dd, J = 1.0, 7.5 Hz, 2 H, ArH), 7.46 (d, J = 8.5 Hz, 2 H, 
C6H4OMe), 7.40 – 7.32 (m, 4 H, ArH), 6.89 (d, J = 10.0 Hz, 2 H, C6H4OMe), 5.70 – 5.52 (m, 3 H, H-3', 
CH=CH of COE), 5.47 (s, 1 H, MeOPhCH), 5.37 (dd, J = 6.5, 9.0 Hz, 1 H, H-2'), 5.08 (d, J = 8.5 Hz, 1 H, 
H-1), 5.00 (dd, J = 2.0, 7.5 Hz, 1 H, H-1'), 4.74 (td, J = 3.5 , 7.5 Hz, 1 H, H-3), 4.37 (dd, J = 8.5, 10.0 Hz, 1 
H, H-4'), 4.32 (d, J = 3.5 Hz, 1 H, H-4), 4.27 (dd, J = 1.0, 11.5 Hz, 1 H, H-6), 4.12 (d, J = 9.5 Hz, 1 H, H-
5'), 4.05 (dd, J = 4.0, 12.0 Hz, 1 H, H-6), 3.95 (td, J = 4.5, 10.0 Hz, 1 H, OCH2CH2O), 3.82 (s, 3 H, 
CO2CH3), 3.79 (s, 3 H, PhOCH3), 3.70 - 3.63 (m, 1 H, OCH2CH2O), 3.62 – 3.56 (m, 2 H, OCH2CH2O), 
3.55 – 3.43 (m, 5 H, H-5, OCH2CH2O), 3.43 – 3.35 (m, 1 H, H-2), 3.35 – 3.28 (m, 1 H, OCH of COE), 2.38 
– 2.28 (m, 1 H, CH2 of COE), 2.18 – 2.08 (m, 1 H, CH2 of COE), 2.08 – 1.98 (m, 1 H, CH2 of COE), 1.96 – 
1.84 (m, 1 H, CH2 of COE), 1.82 – 1.60 (m, 4 H, CH2 of COE), 1.55 (s, 3 H, NCOCH3), 1.50 – 1.32 (m, 2 
H, CH2 of COE), 0.74 (s, 9 H, SiC(CH3)3), -0.05 (s, 3 H, SiCH3), -0.21 (s, 3 H, SiCH3); 13C NMR (75 MHz, 
CDCl3): δ 171.3, 168.7, 165.6, 164.8, 159.8, 133.2, 133.1, 130.5, 129.7, 129.4, 129.3, 127.6, 113.3, 101.3, 
100.5, 98.9, 81.0, 77.2, 76.0, 75.7, 75.5, 75.4, 72.1, 70.6, 70.5, 70.2, 69.1, 68.3, 67.5, 66.4, 55.2, 54.2, 52.5, 
34.1, 33.4, 25.7, 25.6, 25.3, 23.2, 22.5, 17.7, -4.5, -5.2; ESI MS: m/z calcd for [C55H73NO17Si + H]+: 
1048.4, obsd 1048.5. 
 
2-(2-(Cyclooct-4-enyloxy)ethoxy)ethyl (methyl 2,3-di-O-benzoyl-4-O-
tert-butyldimethylsilyl-β-D-glucopyranosyluronate)-(1 → 3)-2-deoxy-2-
acetamido-β-D-galactopyranoside (5):  Acetamide 3a (0.030 g, 0.029 mmol) was dissolved in CH3CN 
(400 µL) and H2O (100 µL). 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone (0.020 g, 0.089 mmol) was 
added. The reaction was stirred at rt for 2 h, quenched with MeOH and concentrated to yield a red solid. 
The product was purified on Sephadex LH-20 (50% CH2Cl2:MeOH) to afford the desired diol 5 as a white 
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solid (0.024 g, 89%). Rf  0.12 (100% EtOAc). 1H NMR (500 MHz, CDCl3): δ 7.86 – 7.78 (m, 4 H, ArH), 
7.52 – 7.44 (m, 2 H, ArH), 7.36 – 7.28 (m, 4 H, ArH), 5.67 – 5.47 (m, 3 H, H-3', CH=CH of COE), 5.31 
(dd, J = 9.0, 10.0 Hz, 1 H, H-2'), 5.04 (dd, J = 1.5, 8.0 Hz, 1 H, H-1'), 4.39 (d, J = 8.5 Hz, 1 H, H-1), 4.26 
(dd, J = 9.0, 9.0 Hz, 1 H, H-4'), 4.20 (dd, J = 2.0, 9.5 Hz, 1 H, H-5'), 4.03 (br s, 1 H, H-4), 3.94 – 3.85 (m, 1 
H, H-2), 3.85 – 3.76 (m, 2 H, H-3, OCH2CH2O), 3.77 (s, 3 H, CO2CH3), 3.70 (dd, J = 6.0, 11.5 Hz, 1 H, H-
6), 3.66 (dd, J = 5.5, 11.5 Hz, 1 H, H-6), 3.63 – 3.56 (m, 1 H, OCH2CH2O), 3.50 – 3.35 (m, 7 H, 
OCH2CH2O, H-5), 3.32 – 3.26 (m, 1 H, OCH of COE), 2.36 – 2.24 (m, 1 H, CH2 of COE), 2.16 – 1.96 (m, 
3 H, CH2 of COE), 1.92 – 1.82 (m, 1 H, CH2 of COE), 1.80 – 1.58 (m, 3 H, CH2 of COE), 1.44 – 1.32 (m, 2 
H, CH2 of COE), 1.90 (d, J = 2.0 Hz, 3 H, NCOCH3), 0.70 (s, 9 H, SiC(CH3)3), -0.05 (s, 3 H, CH3Si), -0.22 
(s, 3 H, CH3Si); 13C NMR (75 MHz, CDCl3): δ 170.4, 167.3, 166.6, 134.7, 134.6, 131.2, 131.1, 130.9, 
130.9, 130.7, 130.7, 129.6, 103.7, 103.0, 82.9, 82.6, 77.4, 76.8, 76.3, 73.5, 72.3, 72.0, 71.7, 69.7, 69.4, 
69.0, 68.9, 62.5, 53.4, 52.5, 35.5, 34.7, 34.6, 26.8, 26.7, 26.2, 23.7, 22.7, 18.8, -3.9, -4.6; ESI MS: m/z calcd 
for [C47H67NO16Si + H]+: 930.4, obsd 930.7. 
 
2-(2-(Cyclooct-4-enyloxy)ethoxy)ethyl (methyl 2,3-di-O-benzoyl-4-O-
tert-butyldimethylsilyl-β-D-glucopyranosyluronate)-(1 → 3)-4,6-di-O-
sodium sulfonato-2-deoxy-2-acetamido-β-D-galactopyranoside (6): Diol 5 (0.145 g, 0.156 mmol) was 
dissolved in DMF (7 mL), and SO3•TMA (0.550 g, 3.96 mmol) was added. After stirring at 50 °C 
overnight, the reaction mixture was cooled to rt, quenched with MeOH and concentrated to afford a yellow 
solid. Purification on Sephadex LH-20 (50% CH2Cl2:MeOH) followed by silica gel chromatography (5:2:1 
MeOH:EtOAc:H2O) afforded 6 (0.144 g, 85%) as a white solid. Rf 0.35 (5:2:1 MeOH:EtOAc:H2O). 1H 
NMR (500 MHz, CD3OD): δ 7.80 (d, J = 8.0 Hz, 2 H, ArH), 7.78 (d, J = 8.0 Hz, 2H, ArH), 7.45 (t, J = 7.0 
Hz, 2 H, ArH), 7.34 – 7.26 (m, 4 H, ArH), 5.78 – 5.50 (m, 3 H, H-3', CH=CH of COE), 5.34 (dd, J = 7.5, 
9.0 Hz, 1 H, H-2'), 5.05 (dd, J = 2.5, 7.0 Hz, 1 H, H-1'), 4.89 (s, 1 H, H-4), 4.40 (dd, J = 2.5, 8.0 Hz, 1 H, 
H-1), 4.35 (dd, J = 9.0 Hz, 1 H, H-4'), 4.33 (dd, J = 5.0, 11.5 Hz, 1 H, H-6), 4.17 (dd, J = 8.0, 11.0 Hz 1 H, 
H-6), 4.13 (d, J = 9.0 Hz, 1 H, H-5'), 4.00 – 3.92 (m, 1 H, H-2), 3.92 – 3.82 (m, 2 H, H-3, H-5),  3.82 – 3.74 
(m, 1 H, OCH2CH2O ), 3.76 (s, 3 H, CO2CH3), 3.64 – 3.56 (m, 1 H, OCH2CH2O), 3.54 – 3.34 (m, 6 H, 
OCH2CH2O), 3.34 – 3.26 (m, 1 H, OCH of COE), 2.34 – 2.24 (m, 1 H, CH2 of COE), 2.12 – 2.04 (m, 2 H, 
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CH2 of COE), 2.04 – 1.94 (m, 1 H, CH2 of COE), 1.92 – 1.80 (m, 1 H, CH2 of COE), 1.78 – 1.58 (m, 3 H, 
CH2 of COE), 1.42 – 1.32 (m, 2 H, CH2 of COE), 1.38 (s, 3 H, NHCOCH3), 0.66 (s, 9 H, SiC(CH3)3),  -
0.07 (s, 3 H, SiCH3), -0.23 (s, 3 H, SiCH3); 13C NMR (75 MHz, CDCl3): δ 170.6, 170.3, 167.3, 167.0, 
134.7, 134.6, 131.1, 130.9, 130.8, 130.8, 130.7, 130.6, 129.6, 129.5, 103.5, 103.1, 82.6, 82.6, 79.6, 77.4, 
77.1, 74.2, 74.1, 72.0, 71.9, 71.6, 70.1, 69.1, 68.9, 68.9, 53.5, 52.7, 35.5, 35.4, 34.7, 34.6, 26.8, 26.7, 26.2, 
23.7, 22.9, 18.8, -3.9, -4.5; ESI MS: m/z calcd for [C47H67NO22S2Si + Na – 2 H]–: 1110.3, obsd 1110.5. 
 
2-(2-(Cyclooct-4-enyloxy)ethoxy)ethyl (sodium β-D-glucopyranosyl- 
uronate)-(1 → 3)-4,6-di-O-sodium sulfonato-2-deoxy-2-acetamido-β-D-
galactopyranoside (7):  Disaccharide 6 (0.030 g, 0.027 mmol) was dissolved in pyridine (150 µL) and 
THF (150 µL) and cooled to 0 °C. HF•pyridine (40 µL, 70% HF in pyridine) was added and the reaction 
was slowly warmed to rt. After 12 h, the mixture was passed through a Sephadex LH-20 column (50% 
CH2Cl2:MeOH) to obtain the crude alcohol. The alcohol (0.025 g, 0.025 mmol) was dissolved in THF (400 
µL) and H2O (200 µL), and to this was added 1 M LiOH (100 µL) and H2O2 (50 µL, 30 wt% solution in 
H2O). After stirring at rt for 12 h, 4 M NaOH (80 µL) and MeOH (400 µL) were added, and stirring was 
continued for another 12 h. The reaction was neutralized with Amberlyst IR-120 resin, filtered and 
lyophilized to afford an orange solid. The product was purified on Sephadex G-10 (100% H2O) and 
Sephadex SP C25 (100% H2O) and lyophilized to afford 7 (0.018 g, 89%, 2 steps) as a white solid. 1H 
NMR (600 MHz, CD3OD): δ 5.62 – 5.47 (m, 2 H, CH=CH of COE), 4.68 (br s, 1 H, H-4), 4.44 (d, J = 7.8 
Hz, 1 H, H-1), 4.33 (d, J = 7.8 Hz, 1 H, H-1'), 4.15 (d, J = 9.0 Hz, 1 H, H-6), 4.05 (dd, J = 9.6 Hz, 1 H, H-
6'), 3.98 – 3.89 (m, 3 H, H-2, H-3, H-5), 3.88 – 3.82 (m, 1 H, OCH2CH2O), 3.72 – 3.64 (m, 1 H, 
OCH2CH2O), 3.60 – 3.46 (m, 6 H, H-5', OCH2CH2O), 3.46 – 3.43 (m, 1 H, OCH2CH2O), 3.39 (dd, J = 9.0, 
9.0 Hz, 1 H, H-4'), 3.42 – 3.34 (m, 1 H, OCH of COE), 3.31 (dd, J = 9.0, 9.0 Hz, 1 H, H-3'), 3.22 (dd, J = 
8.4, 8.4 Hz, 1 H, H-2'), 2.24 – 2.16 (m, 1 H, CH2 of COE), 2.11 – 1.90 (m, 3 H, CH2 of COE), 1.89 (d, J = 
3.0 Hz, 3 H, CH2 of COE), 1.88 – 1.80 (m, 1 H, CH2 of COE), 1.68 – 1.48 (m, 3 H, NCOCH3), 1.36 – 1.24 
(m, 2 H, CH2 of COE); 13C NMR (75 MHz, CDCl3): δ 178.4, 177.4, 132.8, 106.0, 103.7, 84.2, 79.0, 78.9, 
77.8, 77.5, 75.4, 75.2, 75.0, 74.5, 72.7, 72.2, 71.8, 70.6, 69.4, 54.3, 36.1, 35.6, 27.9, 27.7, 25.0, 27.7; ESI 
MS: m/z calcd for [C26H43NO20S2 + 2Na – 3H]–: 796.1, obsd 796.2. 
O
O
HO
HO
HO O
O
O
2
O
3
SOO
2
C
7
OSO
3
AcHN
 S7 
 
 2-(2-(Cyclooct-4-enyloxy)ethoxy)ethyl (methyl 2,3-di-O-
benzoyl-4-O-tert-butyldimethylsilyl-β-D-glucopyranosyl- 
uronate)-(1 → 3)-(4,6-O-p-methoxybenzylidene-2-deoxy-2-trichloroacetamido-β-D-galactopyranosyl)-
(1 → 4)-(methyl 2,3-di-O-benzoyl-β-D-glucopyranosyluronate)-(1 → 3)-4,6-O-p-methoxybenzylidene-
2-deoxy-2-trichloroacetamido-β-D-galactopyranoside (12a):  A mixture of donor 1 (0.050 g, 0.048 
mmol) and acceptor 4 (0.064 g, 0.058 mmol) was co-evaporated with toluene (3 x 3 mL) and dried under 
vacuum overnight. The mixture was dissolved in CH2Cl2 (1.2 mL), and activated 4Å powdered molecular 
sieves were added. The reaction was cooled to -75 °C and stirred for 30 min. Trimethylsilyl 
trifluoromethanesulfonate (1 M in CH2Cl2, 11 µL, 0.011 mmol) at -75 °C was added to the reaction 
dropwise. The reaction was warmed to -15 °C, stirred for 30 min, quenched with triethylamine, filtered and 
concentrated to afford a yellow syrup. Purification by flash chromatography (30% EtOAc:toluene) afforded 
the desired tetrasaccharide 12a (0.044 g, 45%) as a white solid. Rf 0.50 (60% EtOAc:hexanes). 1H NMR 
(500 MHz, CDCl3): δ 7.92 – 7.88 (m, 4 H, ArH), 7.86 (dd, J = 1.0, 8.0 Hz, 2 H, ArH), 7.83 (dd, J = 1.0, 8.0 
Hz, 2 H, ArH), 7.54 – 7.44 (m, 6 H, ArH, C6H4OMe), 7.37 – 7.26 (m, 8 H, ArH), 7.07 (d, J = 11.5 Hz, 2 H, 
C6H4OMe), 6.94 (d, J = 7.0 Hz, 2 H, C6H4OMe), 6.91 (d, J = 6.5 Hz, 1 H, NH), 6.74 (d, J = 6.5 Hz, 2 H, 
C6H4OMe), 6.66 (d, J = 8.5 Hz, 1 H, NH), 5.59 (dd, J = 8.0, 8.0 Hz, 1 H, H-3'), 5.70 – 5.55 (m, 2 H, 
CH=CH), 5.50 (s, 1 H, MeOPhCH), 5.45 (dd, J = 8.5, 8.5 Hz, 1 H, H-3'), 5.37 (dd, J = 7.0, 8.5 Hz, 2 H, H-
2'), 5.20 (s, 1 H, MeOPhCH), 5.16 (d, J = 6.5 Hz, 1 H, H-1'), 5.11 (d, J = 8.0 Hz, 1 H, H-1), 5.04 (d, J = 
7.0Hz, 1 H, H-1'), 4.97 (d, J = 8.5 Hz, 1 H, H-1), 4.66 (ddd, J = 1.5, 3.5, 11.0 Hz, 1 H, H-3), 4.60 (dd, J = 
9.5, 9.5 Hz, 1 H, H-4'), 4.42 – 4.32 (m, 3 H, H-3, H-4, H-4'), 4.30 (d, J = 12.5 Hz, 1 H, H-6), 4.17 (d, J = 
9.5 Hz, 1 H,  H-5'), 4.17 (s, 1 H. H-4), 4.09 (d, J = 9.5 Hz, 1 H, H-5'), 4.05 (d, J = 11.0 Hz, 1 H, H-6), 4.02 
– 3.96 (m, 1 H, OCH2CH2O), 3.84 (s, 3 H, OCH3), 3.81 (s, 6 H, OCH3), 3.79 (s, 3 H, OCH3), 3.86 – 3.66 
(m, 5 H, H-2, H-6, OCH2CH2O), 3.64 – 3.60 (t, J = 4.5 Hz, 2 H, OCH2CH2O), 3.56 – 3.44 (m, 5 H, H-5, 
OCH2CH2O), 3.36 – 3.30 (m, 1 H, OCH of COE), 3.15 (br s, 1 H, H-5), 2.40 – 2.26 (m, 1 H, CH2 of COE), 
2.18 – 1.84 (m, 3 H, CH2 of COE), 1.82 – 1.60 (m, 3 H, CH2 of COE), 1.52 – 1.24 (m, 3 H, CH2 of COE), 
0.73 (s, 9 H, SiC(CH3)3), -0.80 (s, 3 H, SiCH3), -0.23 (s, 3 H, SiCH3); 13C NMR (125 MHz, CDCl3): δ 
168.6, 168.3, 165.5, 165.2, 165.1, 164.9, 162.1, 161.7, 159.9, 159.6, 133.2, 133.1, 132.9, 130.3, 130.0, 
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129.9, 129.8, 129.7, 129.6, 129.4, 129.3, 129.3, 129.0, 128.9, 128.3, 128.3, 128.2, 128.2, 127.0, 127.0, 
113.4, 113.1, 100.5, 100.2, 100.1, 99.9, 98.7, 98.4, 80.9, 76.1, 75.5, 75.3, 74.8, 74.1, 73.7, 73.2, 73.1, 71.8, 
71.6, 70.7, 70.5, 70.3, 69.0, 68.5, 68.1, 67.6, 67.6, 66.5, 55.3, 55.2, 55.0, 54.4, 53.1, 52.5, 34.1, 34.1, 33.4, 
33.4, 25.7, 25.6, 25.6, 25.3, 22.6, 17.6, -4.5, -5.2; ESI MS: m/z calcd for [C92H104Cl6N2O31Si + H]+: 1971.4, 
obsd 1971.6.  
 
          2-(2-(Cyclooct-4-enyloxy)ethoxy)ethyl (methyl 2,3-di-O-
benzoyl-4-O-tert-butyldimethylsilyl-β-D-glucopyranosyl-
uronate)-(1 → 3)-(4,6-O-p-methoxybenzylidene-2-deoxy-2-acetamido-β-D-galactopyranosyl)-(1 → 4)-
(methyl 2,3-di-O-benzoyl-β-D-glucopyranosyluronate)-(1 → 3)-4,6-O-p-methoxybenzylidene-2-deoxy-
2-acetamido-β-D-galactopyranoside (12b):  To a solution of tetrasaccharide 12a (0.11 g, 0.056 mmol) in 
benzene (2.0 mL) were added tributylstannane (200 µL, 0.74 mmol) and 2,2'-azobisisobutyronitrile (6.0 
mg). After stirring at rt for 45 min, the reaction was then heated to 80 °C and stirred for an additional 3 h. 
The mixture was cooled to rt and concentrated to afford a white solid. Purification by flash chromatography 
(50 → 100% EtOAc:hexanes) afforded the desired acetamide 12b (0.088 g, 89 %) as a white solid. Rf  0.20 
(EtOAc). 1H NMR (300 MHz, CDCl3): δ 7.94 (d, J = 8 Hz, 2 H , ArH), 7.90 (d, J = 7.0 Hz, 2 H, ArH), 7.86 
– 7.80 (m, 4 H, ArH), 7.50 – 7.40 (m, 6 H, ArH), 7.38 – 7.26 (m, 8 H, ArH), 7.19 (d, J = 7.5 Hz, 2 H), 6.83 
(d, J = 8.5 Hz, 2 H, ArH),  6.78 (d, J = 7.0 Hz, 2 H), 5.68 (dd, J = 7.0, 12.0 Hz, 1 H), 5.68 – 5.50 (m, 4 H), 
5.47 (dd, J = 8.5, 8.5 Hz, 1 H), 5.30 – 5.23 (m, 2 H, CH=CH of COE), 5.15 (s, 1 H), 5.01 (d, J = 8.5 Hz, 1 
H), 4.98 (dd, J = 6.0, 12.0 Hz, 1 H), 4.96 – 4.90 (m, 1 H), 4.86 (d, J = 6.0 Hz, 1 H), 4.74 (dd, J = 6.0, 6.0 
Hz, 1 H), 4.68 – 4.60 (m, 1 H), 4.53 (dt, J = 2.5, 9.1 Hz, 1 H), 4.38 (br s, 1 H), 4.26 (dd, 1 H, J = 9.0, 9.0 
Hz), 4.24 (d, J = 9.0 Hz, 1 H), 4.16 (dd, J = 1.5, 9.5 Hz, 1 H, H-5’), 4.20 – 4.16 (m, 1 H), 4.03 (d, J = 10.0 
Hz, 1 H, H-5'), 4.01 (d, J = 9.5 Hz, 1 H, H-6), 3.98 (d, J = 3.0 Hz, 1 H), 3.95 – 3.88 (m, 1 H, OCH2CH2O), 
3.78 (s, 3 H, OCH3), 3.80 – 3.76 (m, 1 H, H-6), 3.77 (s, 3 H, OCH3), 3.71 (s, 3 H, OCH3), 3.68 (s, 3 H, 
OCH3), 3.66 – 3.60 (m, 1 H, OCH2CH2O), 3.58 – 3.54 (m, 3 H, OCH2CH2O), 3.50 – 3.45 (m, 3 H, 
OCH2CH2O, H-6), 3.45 – 3.37 (m, 3 H, H-2, H-5, OCH2CH2O), 3.37 – 3.26 (m, 2 H, OCH of COE, H-2), 
2.77 (s, 1 H, H-5), 2.32 – 2.20 (m, 1 H, CH2 of COE), 2.10 – 2.02 (m, 2 H, CH2 of COE), 2.02 – 1.92  (m, 1 
H, CH2 of COE), 1.92 – 1.80 (m, 1 H, CH2 of COE), 1.78 – 1.70 (m, 1 H, CH2 of COE), 1.68 – 1.58 (m, 2 
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H, CH2 of COE), 1.55 (s, 3 H, CH2 of NCOCH3), 1.47 (s, 3 H, NCOCH3), 1.42 – 1.36 (m, 1 H, CH2 of 
COE), 1.36 – 1.26 (m, 1 H, CH2 of COE), 0.68 (s, 9 H, SiC(CH3)3), -0.13 (s, 3 H, SiCH3), -0.28 (s, 3 H, 
SiCH3); 13C NMR (125 MHz, CDCl3): δ 171.3, 170.9, 168.6, 168.4, 165.6, 164.9, 164.8, 164.7, 159.7, 
159.6, 133.2, 133.1, 130.7, 130.4, 129.9, 129.9, 129.8, 129.6, 129.5, 129.4, 129.4, 129.2, 129.1, 128.4, 
128.4, 128.3, 127.7, 127.6, 113.4, 113.1, 101.0, 100.6, 100.2, 99.3, 99.1, 81.0, 77.2, 75.9, 75.7, 75.5, 75.3, 
75.2, 75.1, 73.7, 73.6, 72.1, 72.0, 70.6, 70.5, 70.3, 69.2, 68.4, 68.2, 67.5, 66.4, 66.2, 55.3, 55.2, 54.1, 53.2, 
52.7, 52.4, 34.1, 34.0, 33.5, 33.4, 25.7, 25.6, 25.3, 23.1, 23.1, 22.5, 17.7, -4.5, -5.2; ESI MS: m/z calcd for 
[C92H110N2O31Si + H]+: 1767.6, obsd 1768.1. 
 
2-(2-(Cyclooct-4-enyloxy)ethoxy)ethyl (methyl 2,3-di-O-
benzoyl-4-O-tert-butyldimethylsilyl-β-D-glucopyranosyl-
uronate)-(1 → 3)-(4,6-di-O-sodium sulfonato-2-deoxy-2-acetamido-β-D-galactopyranosyl)-(1 → 4)-
(methyl 2,3-di-O-benzoyl-β-D-glucopyranosyluronate)-(1 → 3)-4,6-di-O-sodium sulfonato-2-deoxy-2-
acetamido-β-D-galactopyranoside (12):  Acetamide 12b (0.038 g, 0.021 mmol) was dissolved in CH3CN 
(400 µL) and H2O (40 µL). 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone (0.014 g, 0.063 mmol) was added. 
The reaction was stirred at rt for 2 h, quenched with MeOH, and concentrated to yield a red solid. The 
product was purified on Sephadex LH-20 (50% CH2Cl2:MeOH) to afford the crude tetraol 12c as a white 
solid. The tetraol (0.026 g, 0.017 mmol) was dissolved in DMF (700 µL), and SO3•TMA (0.024 g, 3.96 
mmol) was added. After stirring at 50 °C overnight, the reaction was cooled to rt, quenched with MeOH 
and concentrated to afford a yellow solid. The product was purified on Sephadex LH-20 (50% 
CH2Cl2:MeOH) followed by silica gel chromatography (5:2:1 MeOH:EtOAc:H2O) to afford 12 (0.022 g, 
71%) as a white solid. Rf 0.45 (4:1:1 MeOH:EtOAc:H2O). 1H NMR (300 MHz, CD3OD): δ 7.99 (d, J = 8.0 
Hz, 2 H, ArH), 7.95 (dd, J = 1.0, 8.0 Hz, 2 H, ArH), 7.89 (dd, J = 1.0, 8.0 Hz, 2 H, ArH), 7.83 (dd, J = 1.0, 
8.0 Hz, 2 H, ArH), 7.62 – 7.50 (m, 4 H, ArH), 7.44 (t, J = 7.0, 7.5 Hz, 4 H, ArH), 7.40 – 7.32 (m, 4 H, 
ArH), 5.72 – 5.54 (m, 4 H, CH=CH, H-3'), 5.42 – 5.30 (m, 2H, H-2'), 5.14 (dd, J = 3.0, 6.0 Hz, 1 H), 5.05 
(s, 1 H, H-4), 4.84 (d, J = 2.0 Hz, 1 H, H-4), 4.70 – 4.62 (m, 2 H), 4.48 (dd, J = 1.5, 8.0 Hz, 1 H),  4.46 – 
4.40 (m, 2 H), 4.36 (dd, J = 1.5, 9.5 Hz, 1 H), 4.28 (dd, J = 7.5, 11.5 Hz, 1 H), 4.17 (d, J = 9.0 Hz, 1 H), 
4.12 (dd, J = 5.5, 10.5 Hz, 1 H), 4.09 – 4.03 (m, 1 H), 3.98 – 3.80 (m, 7 H), 3.88 (s, 3 H, OCH3), 3.83 (s, 3 
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H, OCH3), 3.76 – 3.66 (m, 2 H), 3.60 – 3.45 (m, 6 H), 3.42 – 3.36 (m, 1 H, OCH of COE), 2.42 – 2.30 (m, 
1 H, CH2 of COE), 2.20 – 2.12 (m, 2 H, CH2 of COE), 2.10 – 2.00 (m, 1 H, CH2 of COE), 2.00 - 1.90 (m, 1 
H, CH2 of COE), 1.80 – 1.60 (m, 3 H, CH2 of COE), 1.51 (s, 3 H, NCOCH3), 1.52 (s, 3 H, NCOCH3), 1.54 
– 1.36 (m, 2 H, CH2 of COE), -0.75 (s, 9 H, SiC(CH3)3), -0.01 (s, 3 H, SiCH3), -0.16 (s, 3 H, SiCH3); ESI 
MS: m/z calcd for [C76H94N2O41S4Si + Na – 2H]+: 1871.4, obsd 1871.5. 
 
Polymerization Procedure for Unprotected CS Monomer 7: In a typical polymerization experiment, a 
small vial was charged with CS monomer 7 (15 mg, 0.20 mmol) and a small stir bar under the flow of 
argon. To this was added 200 µL of MeOH (for catalyst 8) or H2O (for the water-soluble catalyst, H2IMes-
poly(ethyleneglycol)(Cl)2-Ru=CH(o-iPrOC6H4)).3 The desired amount of bis-pyridine catalyst 8 (0.013 M 
stock solution in (CH2Cl)2) or water-soluble catalyst (0.013 M stock solution in water) was added, and the 
reaction mixture was heated to 55 °C.  After stirring at 55 °C for 24 h, the reaction was quenched by the 
addition of ethylvinyl ether (150 µL), passed through a Sephadex G10 UF column (H2O), and lyophilized 
to obtain 9a or 9b as an off-white solid. The lyophilized materials were characterized by 1H NMR. The 
integrations of the phenyl peaks at 7.2 – 7.0 ppm and olefinic peaks at 5.4 – 5.2 ppm (cyclooctene) and 5.6 
– 5.4 ppm (polymerized cyclooctene) were used to obtain the DP values and the extent of conversion. For 
the polymerization with 8 (2.5 mol%), 36% conversion was observed with a DP value of 21. For the 
polymerization with the water-soluble catalyst (2.5 and 5.0 mol%), incomplete conversion (7 and 60%, 
respectively) was observed with DP values of 8 and 28, respectively. 
 
Polymerization Procedure for Protected CS Monomers: In a typical polymerization experiment, a small 
vial was charged with CS monomer (5, 6 or 12; 0.018 mmol) and a small stir bar under the flow of argon. 
To this was added a solution of 5:1 (CH2Cl)2/MeOH (600 µL). The desired amount of bis-pyridine catalyst 
8 (0.013 M stock solution in (CH2Cl)2) was then added via syringe at rt. The reaction mixture was heated to 
55 °C and stirred at this temperature for 24 h. At this point, TLC of the crude reaction mixture showed 
complete consumption of starting material. The polymerization process was quenched by the addition of 
ethyl vinyl ether (0.3 mL), and the resultant precipitate was filtered and washed with diethyl ether. The 1H 
NMR of the crude product showed the disappearance of the cyclooctene methylene protons between 2.4-
 S11 
2.2 ppm, indicating the completion of the polymerization reaction. Further confirmation of the 
polymerization reaction was established by 1H NMR of the crude product after desilylation and 
saponification, followed by salt removal using Sephadex G10 UF (H2O). The 1H NMR of the deprotected 
product showed a shift of the olefinic protons from 5.6 – 5.4 ppm (sharp multiplet corresponding to 
cyclooctene olefinic protons) to 5.4 – 5.2 ppm (broad peak corresponding to the poly(cyclooctene) 
backbone protons).  
Small CS oligomers were removed from the glycopolymer by dialysis at rt against 0.2 M LiBr in 
DMSO (Spectra/Por Biotech Dialysis Membranes RC MWCO 8000, 25000 or 50000; 2 x 12 h). The 
polymer was then dialyzed at rt against DMSO without LiBr (3 x 6 h) and lyophilized to dryness to yield a 
white solid. All glycopolymers were characterized by 1H NMR spectroscopy and gel permeation 
chromatography (GPC). GPC was carried out in 0.2 M LiBr in DMF on two I-series Mixed Bed Low MW 
ViscoGel columns (Viscotek) connected in series with a DAWN EOS multiangle laser light scattering 
(MALLS) detector and an Optilab DSP differential refractometer (both from Wyatt Technology). No 
calibration standards were used, and dn/dc values were obtained for each injection assuming 100% mass 
elution from the columns. The polymerization yield and Mw, Mn and PDI values for different CS monomers 
and different catalyst loadings are shown in Table 1. 
 
CS-E disaccharide protected polymer (10): 53 – 88% yield for 0.5 – 5.0 
mol% catalyst. 1H NMR (500 MHz, D2O): δ 8.10 – 7.45 (m, 10 H), 5.60 – 
5.02 (m, 6 H, H-1', H-2', H-3', CH=CH), 4.65 – 4.00 (m, 6 H, H-1, H-4, H-5, H-6, H-4'), 4.00 – 3.20 (m, 11 
H, H-2, H-3, H-5, CH2CH2O), 3.76 (s, 3 H, COOCH3), 3.20 – 3.10 (m, 1 H, OCH of COE), 2.04 – 1.80 (m, 
3 H), 1.49 (s, 3 H), 1.43 – 1.11 (m, 7 H), 0.66 (s, 9 H, SiC(CH3)3), -0.06 (s, 3 H, SiCH3), -0.24 (s, 3 H, 
SiCH3). 
 
Unsulfated CS disaccharide protected polymer (11): 69% yield. 1H 
NMR (500 MHz, D2O): δ 7.97 (d, J = 7.5 Hz, 2 H, ArH), 7.88 (d, J = 7.5 
Hz, 2 H, ArH), 7.72 (dd, J = 7.0, 7.0 Hz, 1 H, ArH), 7.67 (dd, J = 7.0, 7.0 Hz, 1 H, ArH), 7.59 (dd, J = 7.5, 
7.5 Hz, 2 H, ArH), 7.53 (dd, J = 7.5, 7.5 Hz, 2 H, ArH), 5.75 (dd, J = 9.0, 9.0 Hz, 1 H, H-3'), 5.56 – 5.52 
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(m, 2 H, CH=CH), 5.38 (dd, J = 8.0, 8.0 Hz, 1 H, H-2'), 5.34 (d, J = 7.5 Hz, 1 H, H-1'), 4.56 – 4.50 (m, 2 H, 
H-5'), 4.46 – 4.40 (m, 1 H), 4.37 (dd, J = 9.0, 9.0 Hz, 1 H, H-4'), 4.06 – 4.00 (m, 1 H, H-4), 3.98 – 3.70 (m, 
3 H, H-2, H-3, OCH2CH2O), 3.90 (s, 3 H, OCH3) 3.72 – 3.40 (m, 9 H), 3.38 – 3.28 (m, 1 H, OCH of COE), 
2.20 – 2.00 (m, 4 H), 1.62 – 1.40 (m, 6 H), 1.36 (s, 3 H, NCOCH3), 0.84 (s, 9 H, SiC(CH3)3), 0.09 (s, 3 H, 
SiCH3), -0.08 (s, 3 H, SiCH3).  
 
CS-E tetrasaccharide protected polymer (13): 51% yield. 
1H NMR (500 MHz, D2O): δ 8.00 – 7.20 (m, 20 H), 5.60 – 
4.92 (m, 9 H, H-1, H-1', H-2', H-3', CH=CH), 4.60 – 4.02 (m, 11 H, H-1, H-4, H-5, H-6, H-4'), 3.85 (s, 3 H, 
COOCH3), 3.77 (s, 3 H, COOCH3), 3.20 (m, 3.90, 14 H, H-2, H-3, H-5, OCH2CH2O), 3.20 – 3.10 (m, 1 H, 
OCH of COE), 2.03 – 1.80 (m, 3 H), 1.53 (s, 3 H), 1.42 (s, 3 H), 1.50 – 1.10 (m, 7 H), 0.66 (s, 9 H, 
SiC(CH3)3), -0.07 (s, 3 H, SiCH3), -0.27 (s, 3 H, SiCH3). 
 
Polymer Deprotection Procedure:  The glycopolymer (10, 11 or 13; 0.018 mmol) was dissolved in 
pyridine (120 µL), THF (120 µL) and H2O (28 µL). The reaction was cooled to 0 °C, and HF•pyridine (33 
µL, 70% HF in pyridine) was added. After stirring at 0 °C for 1 h and at rt overnight, the reaction was 
quenched with methoxytrimethylsilane to obtain a brown precipitate. The precipitate was filtered, washed 
with ether and subjected to saponification conditions. The alcohol was deprotected in a manner similar to a 
procedure from Lucas et. al.2 To a solution of the alcohol in THF (152 µL) and H2O (75 µL) at 0 °C were 
added 1 M aq. LiOH (60 µL) and 30% H2O2 (30 µL). The reaction was stirred at 0 °C for 1 h and at rt for 
12 h. At this time, 4 M NaOH (45 µL) and MeOH (224 µL) were added, and the reaction was stirred for 
another 12 h. It was then neutralized with Amberlyst IR-120 resin, filtered and lyophilized to afford an 
orange solid. The product was purified by Sephadex G-25 UF (0.9 % NaCl in H2O) and desalted with 
Sephadex G-25 UF (100% H2O) to afford 14 (87 – 95% yield), 15 (69% yield) or 16 (87% yield) as a white 
solid upon lyophilization.  
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CS-E disaccharide polymer (14): 87 – 95% yield for 0.5 – 5.0 mol% 
catalyst. 1H NMR (500 MHz, D2O): δ 5.46 – 5.30 (m, 2 H, CH=CH), 4.71 
(s, 1 H, H-4), 4.46 (d, J = 5.0 Hz, 1 H, H-1), 4.37 (d, J = 7.5 Hz, 1 H, H-1'), 4.17 (d, J = 10.5 Hz, 1 H, H-6), 
4.07 (dd, J = 9.5, 9.5 Hz, 1 H, H-6),  4.02 – 3.82 (m, 4 H, H-2, H-3, H-5, OCH2CH2O), 3.74 – 3.48 (m, 8 H, 
H-5', OCH2CH2O), 3.41 (dd, J = 8.5 Hz, 1 H, H-4'), 3.36 (dd, J = 8.0, 8.5 Hz, 1 H, H-3'), 3.40 – 3.30 (m, 1 
H, OCH of COE), 3.23 (dd, J = 8.0, 8.0 Hz, 1 H, H-2'), 1.91 (s, 3 H, NCOCH3), 2.08 – 1.80 (m, 4 H, CH2 
of COE), 1.70 - 1.10 (m, 6 H, CH2 of COE). 
 
Unsulfated CS disaccharide polymer (15):  69% yield. 1H NMR (500 
MHz, D2O): δ 5.60 – 5.20 (m, 2 H, CH=CH), 4.34 (d, J = 8.0 Hz, 1 H, H-1), 
4.30 (d, J = 7.0 Hz, 1 H, H-1'), 4.11 (d, J = 2.0 Hz, 1 H, H-4), 4.00 – 3.90 (m, 2 H, H-2, H-6), 3.80 – 3.50 
(m, 13 H, H-3, H-5, H-6, H-5', OCH of COE, OCH2CH2O), 3.44 (dd, J = 9.0, 9.0 Hz, 1 H, H-3'), 3.41 (dd, 
J = 9.5, 9.5 Hz, 1 H, H-2'), 3.28 (dd, J = 8.0, 8.0 Hz, 1 H, H-1'), 1.96 (s, 3 H, NCOCH3), 2.40 – 1.80 (m, 4 
H), 1.70 – 1.00 (m, 6 H). 
 
CS-E tetrasaccharide polymer (16): 87% yield. 1H NMR 
(500 MHz, D2O): δ 5.60 – 5.30 (m, 2 H, CH=CH), 4.74 – 
4.72 (m, 2 H, H-4), 4.62 – 4.52 (m, 2 H, H-1), 4.48 (d, J = 7.0 Hz, 1 H, H-1'), 4.46 (d, J = 7.0 Hz, 1 H, H-
1'), 4.30 – 3.90 (m, 11 H, H-2, H-3, H-5, H-6, OCH2CH2O), 3.84 – 3.52 (m, 12 H, H-3', H-4', H-5', H-5', 
OCH of COE, OCH2CH2O), 3.49 (dd, J = 8.5, 8.5 Hz, 1 H, H-4'), 3.43 (dd, J = 8.0, 8.0 Hz, 1 H, H-3'), 3.36 
(dd, J = 8.5, 8.5 Hz, 1 H, H-2'), 3.30 (dd, J = 8.0, 8.0 Hz, 1 H, H-2'), 1.94 (s, 3 H, NCOCH3), 1.91 (s, 3 H, 
NCOCH3), 2.20 – 1.60 (m, 4 H, CH2 of COE), 1.60 – 1.10 (m, 6 H, CH2 of COE). 
 
Treatment of Hippocampal Neurons with the CS-E Polysaccharide and CS Glycopolymers.  
Hippocampal neuronal cultures were prepared using a procedure modified from Goslin and Banker.4 
Briefly, hippocampi of embryonic day 18 (E18) rats were dissected and transferred to 4.5 mL of ice-cold 
Calcium and Magnesium Free-Hank’s Balanced Salt Solution (CMF-HBSS).  Trypsin (2.5%, no EDTA) 
was added to 5 mL, and the tissue was incubated for 15 min at 37 °C.  The trypsin solution was removed 
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and the tissue sample washed three times with 5 mL of CMF-HBSS.  Cells were then dissociated from the 
tissue in 1 mL of CMF-HBSS by passing through a P1000 pipette tip twenty times.  The cells were 
counted, diluted into Minimal Eagle’s Medium (MEM) plus 10% fetal bovine serum, and seeded on glass 
coverslips (Carolina Biological) coated with 15 µg/mL poly-DL-ornithine at a density of 70 cells/mm2 for 
30 min.  After this time, 500 µL of supplemented Neurobasal medium (47.5 mL Neurobasal medium 
without L-glutamine; 0.5 mL L-glutamine (200 mM); 0.5 mL penicillin/streptomycin (10,000 U/mL); 0.5 
mL antibiotic-antimycotic (100X stock); 1.0 mL B-27 serum-free supplement (50X stock); 50 µL of 0.5 M 
kynurenic acid in 1 N NaOH) was added to each coverslip.  The cultures were incubated in 5% CO2 at 37 
°C for 24 h.  The media was then removed, and a 1.25 µL solution of CS-E polysaccharide (Seikagaku; 
~60% of the polysaccharide is estimated to contain the CS-E motif) or glycopolymer in 3.5 M aq. NaCl was 
added to supplemented Neurobasal medium (498.75 µL) on each coverslip.  A fixed uronic acid 
concentration of 0.5 µg/mL was used in each case to compare the effects of multivalency.  This 
concentration corresponded to molar concentrations of 14.3 nM for the natural CS-E polysaccharide and 
53.0 nM, 33.2 nM, 22.9 nM, and 16.6 nM for glycopolymer 14 with DP values of 25, 40, 58 and 80, 
respectively.  The molar concentrations of glycopolymers 11 and 16 were 43.2 nM and 12.1 nM, 
respectively.  Importantly, no cellular toxicity was observed at the concentrations used for each compound, 
as demonstrated by adherence of the cells to the coverslip and healthy cellular morphology.  The cultures 
were incubated for an additional 24 h in 5% CO2 at 37 °C and analyzed as described below.   
Concentrations of the CS-E polysaccharide and glycopolymers were determined by measuring 
their relative uronic acid contents using the carbazole reaction.5  Briefly, the acid borate reagent (1.5 mL of 
0.80 g sodium tetraborate, 16.6 mL H2O, and 83.3 mL H2SO4) was added to 15-mL glass test tubes.  The 
polysaccharide and glycopolymers (5 µL of a 10 mg/mL stock in 3.5 M NaCl) were added and the solution 
placed in a boiling H2O bath for 10 min.  Following addition of the carbazole reagent (50 µL of 0.1% w/v 
carbazole in 100% EtOH), the solution was boiled for 15 min.  The absorbance was read at 530 nm and 
compared to a D-glucuronolactone standard in H2O.  From these readings, stock solutions containing 200 
µg/mL uronic acid in 3.5 M aq. NaCl were made for each compound and used for treatments of neurons.   
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Determining the Relative Potencies of the Natural Polysaccharide and Glycopolymer 16.  
Hippocampal neurons were grown for 24 h before medium was replaced with fresh supplemented 
Neurobasal medium, and compounds were added at various uronic acid concentrations ranging from 0.01 
to 0.5 µg/mL.  Neurons were incubated with the compounds for 24 h and then analyzed as described below.  
To determine the IC50 values, the concentrations of the CS-E polysaccharide were calculated based on an 
average molecular weight of 70,000 g/mol, as provided by the manufacturer.  For glycopolymer 16, a 
molecular weight of 84,096 g/mol, as determined by GPC, was used.  The concentration values were 
plotted against the % inhibition of neurite outgrowth relative to untreated neurons, and the IC50 values 
represent molar concentrations of compound needed for 50% inhibition of neurite outgrowth.  IC50 values 
of 1.2 ± 0.1 nM and 1.3 ± 0.1 nM were determined for the natural polysaccharide and glycopolymer 16, 
respectively (1.2 ± 0.1 nM and 1.6 ± 0.1 nM if calculated based on the saccharide content of each 
molecule). 
 
Immunocytochemistry of Hippocampal Neuronal Cultures.  After 48 h in culture, the hippocampal 
neurons on coverslips were rinsed one time with PBS, fixed in 4% paraformaldehyde for 20 min at rt, 
washed twice with PBS, permeabilized in 0.3% Triton X-100 for 5 min at rt, and washed twice with PBS. 
Non-specific binding was blocked by incubating with 3% BSA for 1 h at rt and then rinsing once with PBS.  
Cells were then incubated with anti-tubulin antibodies (rabbit polyclonal, 1:500; Sigma) in 3% BSA 
overnight at 4 °C.  Excess antibody was rinsed away 5 times with PBS.  Secondary antibody, anti-rabbit 
IgG AlexaFluor 488 (1:500; Molecular Probes), was added for 1 h at 37 °C in 3% BSA.  Excess secondary 
antibody was washed off 5 times with PBS.  The coverslips were mounted onto glass slides using 
Vectashield mounting medium (Vector Labs) and sealed with clear nail polish.  Cells were imaged on a 
Nikon Eclipse TE2000-S inverted microscope.  The images were captured with MetaMorph 6.1 software 
using a 40x plan fluor oil objective.  
 
Morphometric Analysis.  All experiments were performed in triplicate.  For each experiment, 25 
randomly selected cells were analyzed per coverslip. To ensure accurate measurements, only neurites 
longer than ~10 µm and not in contact with other cells were measured using MetaMorph 6.1 software.  The
 S16 
mean neurite lengths were compared among the different conditions by the ANOVA test using the 
statistical analysis program in KaleidaGraph 4.0.   
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Figure S1. A monovalent CS-E tetrasaccharide displays no inhibitory activity, whereas the CS-E 
terasaccharide glycopolymer 16 completely inhibits neurite outgrowth.  Hippocampal neurons were 
treated with 0.5 µg/mL uronic acid equivalents of a monovalent tetrasaccharide6 or glycopolymer 16.   
 
 
 
 
 
 
 
 
 
 
Untreated CS-E Tetra CS-E Tetra polymer
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